Search Article Keyword:  

PubMed Submission Abstract PDF Feed Back Count: 825 Download Count: 291 

ISSN 1007-9327 CN 14-1219/R  World J Gastroenterol  2008 April 7; 14(13): 2044-2048
                                                                                                                                         
    RAPID COMMUNICATION
Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease

Satoshi Mamori, Yasuyuki Searashi, Masato Matsushima, Kenichi Hashimoto, Shinichiro Uetake, Hiroshi Matsudaira, Shuji Ito, Hisato Nakajima, Hisao Tajiri


Satoshi Mamori, Yasuyuki Searashi, Shinichiro Uetake, Hiroshi Matsudaira, Shuji Ito, Hisato Nakajima, Hisao Tajiri, Division of Gastroenterology and Hepatology, Department of Internal Medicine, the Jikei University School of Medicine, Tokyo 105-8461, Japan

Masato Matsushima, Division of Clinical Research and development, the Jikei University School of Medicine, Tokyo 105-8461, Japan

Kenichi Hashimoto, Tokyo Medical Center of Alcohol Related Disabilities, Tokyo 175-0091, Japan

Author contributions: Mamori S and Searashi Y contributed equally to this work; Mamori S designed research; Hashimoto K, Searashi Y, and Uetake S performed research; Mamori S, Matsushima M, Matsudaira H, and Ito S analyzed data; Mamori S wrote the manuscript.

Correspondence to: Satoshi Mamori, MD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, the Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. mamori@jikei.ac.jp

Telephone: +81-3-34331111-3201  Fax: +81-3-34350569

Received: November 30, 2007        Revised: January 28, 2008

  

Abstract

AIM: To determine factors predictive for esophageal varices in severe alcoholic disease (SAD).

 

METHODS: Abdominal ultrasonography (US) was performed on 444 patients suffering from alcoholism. Forty-four patients found to have splenomegaly and/or withering of the right liver lobe were defined as those with SAD. SAD patients were examined by upper gastrointestinal (UGI) endoscopy for the presence of esophageal varices. The existence of esophageal varices was then related to clinical variables.

 

RESULTS: Twenty-five patients (56.8%) had esophageal varices. A univariate analysis revealed a significant difference in age and type IV collagen levels between patients with and without esophageal varices. A logistic regression analysis identified type collagen as the only independent variable predictive for esophageal varices (P = 0.017). The area under the curve (AUC) for type IV collagen as determined by the receiver operating characteristic (ROC) for predicting esophageal varices was 0.78.

 

CONCLUSION: This study suggests that the level of type collagen has a high diagnostic accuracy for the detection of esophageal varices in SAD.

 

© 2008 WJG. All rights reserved.

 

Key words: Type IV collagen; Esophageal varice; Alcoholic disease; Abdominal ultrasonography; Alcoholism

 

Peer reviewers: Kazuma Fujimoto, Professor, Department of Internal Medicine, Saga Medical School, Nabeshima, Saga, Saga 849-8501, Japan; Volker F Eckardt, Chief, MD, Professor, Department of Gastroenterology, Deutsche Klinik für Diagnostik, Aukammallee 33, Wiesbaden 65191, Germany; Hitoshi Togashi, Associate Professor, Department of Gastroenterology, Course of Internal Medicine and Therapeutics, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan

 

Mamori S, Searashi Y, Matsushima M, Hashimoto K, Uetake S, Matsudaira H, Ito S, Nakajima H, Tajiri H. Serum type collagen level is predictive for esophageal varices in patients with severe alcoholic disease. World J Gastroenterol 2008; 14(13): 2044-2048  Available from: URL: http://www.wjgnet.com/1007-9327/14/2044.asp  DOI: http://dx.doi.org/10.3748/wjg.14.2044

  

INTRODUCTION

Regular daily drinking is more likely to result in liver damage than intermittent drinking. The longer this pattern is maintained, the more likely it is that alcoholic hepatitis, and subsequently cirrhosis, will develop[1]. In patients with cirrhosis, the incidence of esophageal varices increases by nearly 5% per year, and the rate of progression from small to large varices is approximately 5%-10% per year[2,3]. Bleeding from esophageal varices is common among patients with cirrhosis. Bleeding from varices may occur in 15%-68% of patients with varices[4]. Variceal hemorrhaging is associated with a high mortality and with high hospital costs[5]. Both, beta-blockers and endoscopic procedures, have been established as effective preventive modalities for variceal hemorrhage[5,6]. Therefore, the early detection of esophageal varices is critical for the effective prevention of variceal hemorrhage[7]. Adding an accurate serum marker for hepatic fibrosis to the model may improve the diagnostic accuracy in predicting esophageal varices without performing liver biopsy. Moreover, developing an accurate non-invasive diagnostic model might also decrease the costs for the prevention of hemorrhaging from varices[7].

In daily medical practice, it is common to encounter patients with liver damage from chronic alcohol consump-tion. Moreover, when the alcoholic patient is examined, it is often evident that alcoholic liver damage is progressing. Once alcoholic cirrhosis is established, esophageal varices develop in the majority of patients, as found during prolonged follow-up[8]. Nevertheless, alcoholic patients tend to be indifferent regarding self health, and are not likely to undergo periodic consultations. We therefore examined predictive factors for esophageal varices in severe alcoholic disease.

 

MATERIALS AND METHODS

Patients

The 444 consecutive patients considered for this study were hospitalized at the Tokyo Medical Center of Alcohol Related Disabilities in Tokyo, Japan, between April and September 2005, July 2006, and June 2007 for alcoholism.

A complete physical examination was performed by a senior physician. The recorded variables included age, gender, height, body weight, mean alcohol consumption, duration of alcohol abuse, jaundice, ascites, and hepatic encephalopathy.

After an overnight fast, serum samples were obtained from all patients for test purposes, including a complete blood cell count, blood platelets, bilirubin, aspartate transaminase (AST), alanine aminotransferase (ALT), gamma glutamyl transpeptidase (GTP), albumin, prothrombin index (ratio between patient and control Quick time expressed in percentage), and type collagen (Mitsubishi Chemical Medience Corporation, Tokyo, Japan).

     Ultrasonography (US) was performed by experienced gastroenterologists during the stay in hospital. The spleen was visualized with the patient in the right lateral decubitus position. Measurements were then taken in the sagittal (S) and transverse (T) planes, with the maximum dimension being recorded in each plane[9]. Splenomegaly was defined as a spleen index (S × T × 0.9) > 30. Alcoholic patients with splenomegaly and/or withering of the right liver lobe were defined as severe alcoholic disease patients (SAD) and included into the study. Patients with the following criteria were excluded: (1) the presence of suspected hepatocellular carcinoma on US; (2) the presence of extra-hepatic infectious or inflammatory disease; (3) treatment by any drug known to affect liver fibrosis; (4) seropositivity for the hepatitis B surface antigen, hepatitis C virus, and/or human autoimmune antibodies. Finally, we identified 44 SAD patients (Table 1).

     For each patient, upper gastrointestinal (UGI) endoscopy was performed by an endoscopist. The purpose of endoscopy was to evaluate the presence of esophageal varices (Figure 1). The endoscopist evaluated esophageal varices with the Esophagogastric Varices Grading System of the Japan Society for Portal Hypertension[10]. The endoscopist performed UGI endoscopy without knowledge of serum data.

 

Statistical analysis

The results were expressed as the mean ± SD. Differences between the groups were examined for statistical signifi-cance using the Mann-Whitney U test and a c2 test where appropriate. Independent predictive factors associated with esophageal varices were assessed by a multivariate analysis using a logistic regression model. The sensitivity and specificity of collagen type for predicting esophageal varices was determined using receiver operating characteristic (ROC) curves. A P value of less than 0.05 was considered to be statistically significant. All analyses were performed using the STATA 10.0 software program (STATA Corporation, College Station, Texas, USA).

 

RESULTS

Twenty-five patients (56.8%) had esophageal varices, and 19 (43.2%) had no varice (Figure 1). A univariate analysis revealed a significant difference between patients with and without esophageal varices with regard to age and type collagen levels (Table 1 and Figure 2).

     These two variables that were significantly linked to the presence of esophageal varices in the univariate analysis, and a factor previously reported[11], age, PT, and type IV collagen, were assessed by multivariate analysis. A logistic regression analysis identified type collagen as the only independent variable predictive for esophageal varices (P = 0.017)
(Table 2). Whenever the type
IV collagen level raised every 150 ng/mL, the odds ratio of esophageal varices doubled.

Figure 3 shows the positive predictive values at each cut off point of type IV collagen. The positive predictive value of esophageal varices with a type IV collagen value > 900 ng/mL (n = 6) was 100%.

     Finally, the area under the curve (AUC) of type collagen as determined by ROC for predicting the presence of esophageal varices was 0.78 (Figure 4).

 

DISCUSSION

A rupture of esophageal varices is the most frequent complication of portal hypertension, occurring in one third of all cirrhotic patients, and is associated with a high mortality[12,13]. The mortality rate from variceal bleeding is about 20% when patients are treated optimally in a hospital[14]. However, an appreciable proportion of patients with variceal bleeding die before reaching the hospital[15]. Numerous studies have shown that the prevention of UGI bleeding and early detection of esophageal varices reduces mortality, morbidity, and health care costs[16]. Nevertheless, Suzuki et al demanded further studies to determine which strategies are the most beneficial to patients and society in terms of preventing and treating esophageal varices, in a recent article[7]. We thus examined potential esophageal varice prediction factors for SAD on a medical checkup level.

     In this study, a non-invasive marker for hepatic fibrosis (type IV collagen) had a high diagnostic accuracy for the detection of esophageal varices. The combination of abdominal ultrasound scan and this marker correctly identified, at a high rate, patients with esophageal varices. These examinations can be conducted on a medical checkup level, so we considered this approach to be of considerable diagnostic value.

     A previous report showed the type IV collagen concentration was the most accurate in correctly identifying patients with severe histologic alcoholic hepatitis. At a cut-off of 150 ng/mL, type IV collagen was 89% sensitive and 77% specific[17]. First, patient sorting was conducted via the abdominal ultrasound test in this study. The alcoholic patients with splenomegaly and/or withering of the right liver lobe participated in this study. In these 44 patients, the value of type collagen was > 150 ng/mL in all specimens. As a result, when suspecting SAD, we thought it very meaningful to add the abdominal ultrasound test to the characteristics under evaluation.

     In a previous report, Geoffroy and colleagues demonstrated that the independent factors of prothrombin index, alkaline phosphatase activity, and hyaluronate level predicted the presence of esophageal varices[11]. Nevertheless, their proposed model included two age-dependent serum markers, hyaluronate and alkaline phosphatase, both of which rise in serum with aging[18]. We therefore added only the prothrombin index as an examination item. Moreover, another report demonstrated a rise in amino-terminal procollagen III peptide (PIIINP) following alcohol withdrawal that is likely to be caused by intact PNP[19]. We thus decided not to include this fibrosis marker as an examination item at the time of hospitalization. Finally, we elected to add GTP and collagen type IV as examination items.

     The serum concentration of laminin and type IV collagen have been reported to be increased in patients with alcoholic hepatitis and to correlate with the degree of inflammation[20-26]. In our study, logistic regression identified type IV collagen as the only independent variable predictive for esophageal varices. While based on the findings of these studies, laminin may be predictive for esophageal varices. However, the use of such testing is not covered by the national health insurance program in Japan, so we decided to exclude laminin from this study. We therefore hope that further study of esophageal varices in other countries will help to elucidate and confirm the predictive potential of laminin.

     Antler et al found that in younger patients, the most common bleeding sites are those associated with alcoholism (esophageal varices, Mallory-Weiss tears, and hemorrhagic gastritis), accounting for 40%-60% of lesions in patients less than 55 years-of-age[27]. Another report demonstrated that younger patients had a trend toward more variceal bleeds
(P = 0.39)[28]. In our research, there was a positive correlation of esophageal varices with younger age (P > 0.05). We think that younger alcoholic patients with high fibrosis markers should be evaluated by GI endoscopy.

     In conclusion, this study suggests that the level of type collagen has a high diagnostic accuracy for the detection of esophageal varices in SAD. These results show that the non-invasive screening of patients who are at risk for variceal bleeding is possible, and that this approach may assist in the prevention of this most serious complication.

 

COMMENTS

Background

Bleeding from varices may occur in 15%-68% of patients with varices. Variceal hemorrhaging is associated with a high mortality rate, as well as high hospital costs.

 

Research frontiers

The early detection of esophageal varices is critical for the effective prevention of variceal hemorrhaging. Adding an accurate non-invasive diagnostic model may improve the diagnostic accuracy in predicting esophageal varices without performing liver biopsy.

 

Innovations and breakthroughs

First, patient sorting for alcoholism was conducted via the abdominal ultrasound test in this study. The existence of esophageal varices with severe alcoholic disease was compared according to a number of clinical background variables. A univariate analysis revealed a significant difference in age and type IV collagen levels between the patients with and without esophageal varices. A logistic regression analysis identified type IV collagen as the only independent variable predictive for esophageal varices (P = 0.017). AUC of type IV collagen as determined by ROC for predicting expressed esophageal varices was 0.78.

 

Applications

The combination of an abdominal ultrasound scan and type IV collagen correctly identified, at a high rate, alcoholism patients with esophageal varices.

 

Terminology

The type IV collagen and laminin are the major components of basement membranes. Early accumulation of type collagen and laminin, thus leading to the formation of basement membrane-like material in the space of Disse (capillarization), is considered a typical characteristic of alcoholic liver disease. The amount of collagen in the space of Disse has been shown to correlate significantly with the presence of alcoholic hepatitis and portal blood pressure.

 

Peer review

This short paper summarized well the relevance of type collagen as a predictive factor for varices in alcoholic liver cirrhosis.

 

REFERENCES

1         Sutton R, Shields R. Alcohol and oesophageal varices. Alcohol Alcohol 1995; 30: 581-589 PubMed

2         Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O. Incidence and natural history of     small esophageal varices in cirrhotic patients. J Hepatol 2003; 38: 266-272 PubMed

3         D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology 2004;     39: 30-34 PubMed

4         Groszmann RJ, de Franchis R. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC. Schiff’s Disease of the     Liver. Philadelphia, New York: Lippincott-Raven, 1999: 387-442

5         Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 669-681 PubMed

6         Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson     JM, de Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic     symposium. Hepatology 1998; 28: 868-880 PubMed

7         Suzuki A, Mendes F, Lindor K. Diagnostic model of esophageal varices in alcoholic liver disease. Eur J Gastroenterol     Hepatol 2005; 17: 307-309 PubMed

8         Burroughs AK, McCormick PA. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992;     6: 437-450 PubMed

9         Hosey RG, Mattacola CG, Kriss V, Armsey T, Quarles JD, Jagger J. Ultrasound assessment of spleen size in collegiate     athletes. Br J Sports Med 2006; 40: 251-254; discussion 251-254 PubMed

10       Yoshida H, Mamada Y, Taniai N, Tajiri T. New methods for the management of gastric varices. World J Gastroenterol     2006; 12: 5926-5931 PubMed

11       Vanbiervliet G, Barjoan-Marine E, Anty R, Piche T, Hastier P, Rakotoarisoa C, Benzaken S, Rampal P, Tran A. Serum    fibrosis markers can detect large oesophageal varices with a high accuracy. Eur J Gastroenterol Hepatol 2005; 17:    333-338 PubMed

12      Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-809 PubMed

13      D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:    332-354 PubMed

14      D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.    Hepatology 2003; 38: 599-612 PubMed

15      Nidegger D, Ragot S, Berthelemy P, Masliah C, Pilette C, Martin T, Bianchi A, Paupard T, Silvain C, Beauchant M.    Cirrhosis and bleeding: the need for very early management. J Hepatol 2003; 39: 509-514 PubMed

16      Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology    2002; 122: 1620-1630  PubMed

17      Castera L, Hartmann DJ, Chapel F, Guettier C, Mall F, Lons T, Richardet JP, Grimbert S, Morassi O, Beaugrand M,    Trinchet JC. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in    patients with cirrhosis. J Hepatol 2000; 32: 412-418 PubMed

18      Guechot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol 1995; 22: 103-106

          PubMed

19      Campbell S, Timms PM, Maxwell PR, Doherty EM, Rahman MZ, Lean ME, Danesh BJ. Effect of alcohol withdrawal on    liver transaminase levels and markers of liver fibrosis. J Gastroenterol Hepatol 2001; 16: 1254-1259 PubMed

20      Annoni G, Colombo M, Cantaluppi MC, Khlat B, Lampertico P, Rojkind M. Serum type III procollagen peptide and    laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 1989; 9: 693-697 PubMed

21      Lotterer E, Gressner AM, Kropf J, Grobe E, von Knebel D, Bircher J. Higher levels of serum aminoterminal type III    procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity. J Hepatol 1992; 14: 71-77

          PubMed

22      Niemela O, Risteli L, Sotaniemi EA, Risteli J. Type IV collagen and laminin-related antigens in human serum in alcoholic    liver disease. Eur J Clin Invest 1985; 15: 132-137 PubMed

23      Niemela O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Markers of fibrogenesis and basement membrane    formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology    1990; 98: 1612-1619 PubMed

24      Niemela O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Connective tissue metabolism and alcohol intake in    alcoholic liver disease. Alcohol Alcohol Suppl 1991; 1: 351-355 PubMed

25      Nouchi T, Worner TM, Sato S, Lieber CS. Serum procollagen type III N-terminal peptides and laminin P1 peptide in    alcoholic liver disease. Alcohol Clin Exp Res 1987; 11: 287-291 PubMed

26      Robert P, Champigneulle B, Kreher I, Gueant JL, Foliguet B, Dollet JM, Bigard MA, Gaucher P. Evaluation of fibrosis in    the disse space in noncirrhotic alcoholic liver disease. Alcohol Clin Exp Res 1989; 13: 176-180 PubMed

27      Antler AS, Pitchumoni CS, Thomas E, Orangio G, Scanlan BC. Gastrointestinal bleeding in the elderly. Morbidity,    mortality and cause. Am J Surg 1981; 142: 271-273 PubMed

28      Segal WN, Cello JP. Hemorrhage in the upper gastrointestinal tract in the older patient. Am J Gastroenterol 1997; 92:    42-46 PubMed

 

S- Editor  Li DL    L- Editor  Mihm S    E- Editor  Ma WH

 

                                                                                              

 

Reviews Add
more>>


Related Articles:
Endoscopic ligation for benign and malignant lesions of upper digestive tract
Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease
Cost saving by reloading the multiband ligator in endoscopic esophageal variceal ligation: A proposal for developing countries
Comparison of esophageal capsule endoscopy and esophagogastroduodenoscopy for diagnosis of esophageal varices
Per rectal portal scintigraphy as a useful tool for predicting esophageal variceal bleeding in cirrhotic patients
more>>